Anemia of Chronic Disease Diagnosis and Management

Laboratory Interpretation

A pattern of normal iron, low TIBC, and normal saturation suggests anemia of chronic disease (ACD) or chronic inflammation, requiring investigation for underlying conditions, according to Praxis Medical Insights 1, 2
Low TIBC (<250 μg/dL) indicates decreased transferrin production, which occurs in chronic inflammation, malnutrition, liver disease, or nephrotic syndrome, as stated by Praxis Medical Insights 1
Normal transferrin saturation (20-50%) with low TIBC means the limited transferrin present is adequately saturated with iron, arguing against iron deficiency, as noted by Praxis Medical Insights 2
In iron deficiency, TIBC is characteristically elevated (>350 μg/dL) as the body produces more transferrin to capture available iron, according to Gut 3, 4

Serum ferritin is used to assess iron stores and detect inflammation (ferritin is an acute phase reactant), as recommended by Gut 3, 4
C-reactive protein (CRP) is used to confirm the presence of inflammation, according to Praxis Medical Insights 1
Complete blood count with MCV and MCH is used to evaluate for anemia and red cell indices, as suggested by Gut 3, 4

If ferritin is elevated (>100 μg/L), it confirms anemia of chronic disease or inflammation, and underlying chronic inflammatory conditions should be investigated, according to Gut 3, 4 and Praxis Medical Insights 1
If ferritin is low (<30 μg/L), it represents combined iron deficiency and chronic disease, despite the low TIBC, and iron supplementation is indicated, as noted by Gut 3, 4 and Praxis Medical Insights 1
If ferritin is intermediate (30-100 μg/L), consider functional iron deficiency in the setting of chronic disease, and elevated CRP supports inflammatory etiology, according to Praxis Medical Insights 1, 2

Iron therapy may still be warranted if ferritin is <30 μg/L despite low TIBC (true iron deficiency coexisting with chronic disease), as recommended by Gut 3, 4
Iron therapy may also be considered if ferritin is 30-100 μg/L with elevated CRP and anemia (functional iron deficiency), according to Praxis Medical Insights 2
Monitor response to iron therapy with hemoglobin at 4-8 weeks after initiating therapy, and repeat iron studies only after 4-8 weeks, as suggested by Praxis Medical Insights 2

Oral ferrous sulfate 200 mg three times daily is first-line therapy for patients with combined iron deficiency and chronic disease, as indicated by low ferritin (<30 μg/L) and low TIBC, though ferrous gluconate and ferrous fumarate are equally effective 5
Expect hemoglobin rise of 2 g/dL after 3-4 weeks with adequate iron therapy; failure suggests poor compliance, misdiagnosis, continued blood loss, or malabsorption 5